BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 35665122)

  • 1. COVID-19 and liver diseases, what we know so far.
    Elnaggar M; Abomhya A; Elkhattib I; Dawoud N; Doshi R
    World J Clin Cases; 2022 May; 10(13):3969-3980. PubMed ID: 35665122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 and the liver: A 2021 update.
    Spearman CW; Aghemo A; Valenti L; Sonderup MW
    Liver Int; 2021 Sep; 41(9):1988-1998. PubMed ID: 34152690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute Liver Failure in a COVID-19 Patient Without any Preexisting Liver Disease.
    Gurala D; Al Moussawi H; Philipose J; Abergel JR
    Cureus; 2020 Aug; 12(8):e10045. PubMed ID: 32983735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 and the liver: What do we know so far?
    Nasa P; Alexander G
    World J Hepatol; 2021 May; 13(5):522-532. PubMed ID: 34131467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 pathophysiology and assessment of coronaviruses in CNS diseases with a focus on therapeutic targets.
    Vallamkondu J; John A; Wani WY; Ramadevi SP; Jella KK; Reddy PH; Kandimalla R
    Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165889. PubMed ID: 32603829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronavirus diseases and pregnancy: COVID-19,SARS, and MERS.
    Fathi M; Vakili K; Deravi N; Yaghoobpoor S; Ahsan E; Mokhtari M; Moshfeghi M; Vaezjalali M
    Przegl Epidemiol; 2020; 74(2):276-289. PubMed ID: 33112124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver and COVID-19: From care of patients with liver diseases to liver injury.
    Gaspar R; Castelo Branco C; Macedo G
    World J Hepatol; 2021 Oct; 13(10):1367-1377. PubMed ID: 34786172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-alcoholic Fatty Liver Disease and COVID-19 Susceptibility and Outcomes: a Korean Nationwide Cohort.
    Yoo HW; Jin HY; Yon DK; Effenberger M; Shin YH; Kim SY; Yang JM; Kim MS; Koyanagi A; Jacob L; Smith L; Yoo IK; Shin JI; Lee SW
    J Korean Med Sci; 2021 Oct; 36(41):e291. PubMed ID: 34697932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The SARS-CoV-2 Coronavirus and the COVID-19 Outbreak.
    Lauxmann MA; Santucci NE; Autrán-Gómez AM
    Int Braz J Urol; 2020 Jul; 46(suppl.1):6-18. PubMed ID: 32549071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19: from the structure and replication cycle of SARS-CoV-2 to its disease symptoms and treatment.
    Zawilska JB; Lagodzinski A; Berezinska M
    J Physiol Pharmacol; 2021 Aug; 72(4):. PubMed ID: 34987123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological diagnosis of Coronavirus-related nephropathy: insight from postmortem studies.
    Sanguedolce F; Zanelli M; Froio E; Bisagni A; Zizzo M; Ascani S; Stallone G; Netti S; Ranieri E; Falagario U; Carrieri G; Cormio L
    Crit Rev Clin Lab Sci; 2021 Dec; 58(8):563-575. PubMed ID: 34236278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges.
    Lai CC; Shih TP; Ko WC; Tang HJ; Hsueh PR
    Int J Antimicrob Agents; 2020 Mar; 55(3):105924. PubMed ID: 32081636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver dysfunction during COVID-19 pandemic: Contributing role of associated factors in disease progression and severity.
    Sahu T; Pande B; Pl M; Verma HK
    World J Hepatol; 2022 Jun; 14(6):1099-1110. PubMed ID: 35978661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Review of SARS-CoV-2 Disease (COVID-19): Pandemic in Our Time.
    Al-Awwal N; Dweik F; Mahdi S; El-Dweik M; Anderson SH
    Pathogens; 2022 Mar; 11(3):. PubMed ID: 35335691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Insights into COVID-19 Pathophysiology, Immune Pathogenesis, Detection, and Treatment.
    Rezaei Z; Mobasheri L; Sadri F
    DNA Cell Biol; 2021 Jul; 40(7):858-868. PubMed ID: 33989051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary Estimate of Excess Mortality During the COVID-19 Outbreak - New York City, March 11-May 2, 2020.
    New York City Department of Health and Mental Hygiene (DOHMH) COVID-19 Response Team
    MMWR Morb Mortal Wkly Rep; 2020 May; 69(19):603-605. PubMed ID: 32407306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The COVID-19 pandemic.
    Ciotti M; Ciccozzi M; Terrinoni A; Jiang WC; Wang CB; Bernardini S
    Crit Rev Clin Lab Sci; 2020 Sep; 57(6):365-388. PubMed ID: 32645276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel coronavirus pandemic: A clinical overview.
    Kaswa R; Govender I
    S Afr Fam Pract (2004); 2020 Jun; 62(1):e1-e5. PubMed ID: 32633997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 infection in patients with a normal or abnormal liver.
    Cabibbo G; Rizzo GEM; Stornello C; Craxì A
    J Viral Hepat; 2021 Jan; 28(1):4-11. PubMed ID: 33190321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.